Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
Phase 2
Terminated
- Conditions
- Hypocalcemia
- Interventions
- First Posted Date
- 2008-02-26
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00623974
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting
Phase 2
Active, not recruiting
- Conditions
- Lung Cancer
- Interventions
- Other: QuestionnaireBehavioral: Pulmonary Rehabilitation
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00618553
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00614653
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Female Sexual Dysfunction Intervention
Completed
- Conditions
- Sexual Dysfunction
- Interventions
- Behavioral: Focus GroupBehavioral: TENDRILSBehavioral: QuestionnairesBehavioral: Sexual Counseling Sessions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2015-01-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 91
- Registration Number
- NCT00614276
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Phase 1
Completed
- Conditions
- Advanced Cancer
- Interventions
- Procedure: Additional Blood DrawnProcedure: BiopsyProcedure: DCE-MRI Scan
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 193
- Registration Number
- NCT00610493
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Photopheresis for the Treatment of Acute Graft Versus Host Disease
Phase 2
Completed
- Conditions
- Graft Versus Host Disease
- Interventions
- Procedure: Photopheresis
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2018-06-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 81
- Registration Number
- NCT00609609
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Magnetic Resonance Imaging in Patients With Breast Cancer
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: MRI
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 96
- Registration Number
- NCT00610181
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine
Phase 3
Completed
- Conditions
- Unspecified Childhood Solid Tumor, Protocol SpecificUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: educational interventionOther: questionnaire administration
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1356
- Registration Number
- NCT00608933
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
πΊπΈLineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 41
- Registration Number
- NCT00607113
- Locations
- πΊπΈ
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Social-Psychological Aspects of Orbital Exenteration
Completed
- Conditions
- Eye Cancer
- Interventions
- Behavioral: Audio-Taped InterviewBehavioral: Questionnaire
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00601744
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Β© Copyright 2025. All Rights Reserved by MedPath